Crysvita

Product
Active substances: burosumab. Therapeutic area: Hypophosphatemia, Familial;Hypophosphatemic Rickets, X-Linked Dominant;Osteomalacia. ATC code: M05BX05
Reason
Adverse event
Classification
Class II
Category
drug recall
Country
European Union
Agency
EMA-DHPC
Recall date
2025-10-09
Status
Ongoing
Distribution
European Union

Official recall notice from EMA-DHPC

Recall details on Nibble Recalls: https://trynibble.app/recalls/452a2342-a7e4-4521-860c-12e32e390f39